Patents Examined by George Manuel
  • Patent number: 11031729
    Abstract: An implantable blood pump system is disclosed herein. The implantable blood pump system includes an implantable blood pump, a controller coupled to the blood pump, a connector receptacle, and a connector insert. The connector receptacle can include a plurality of contacts, and a following surface. The connector insert can be received within the connector receptacle to couple a plurality of insert contacts with the plurality of contacts of the connector receptacle. The connector insert can include walls defining a follower receptacle that can receive a portion of the following surface when the connector insert is in a desired alignment with respect to the connector receptacle, and a cam surface that can engage with the following surface to bias the connector insert to the desired alignment with respect to the connector receptacle when the connector insert is inserted into the connector receptacle.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: June 8, 2021
    Assignee: TC1 LLC
    Inventors: John Mark Di Paola, Michael McCoy, John Duc Nguyen, Jaime Romero, Dustin Roelle, Andrew Wong, Dmitry Protsenko, Michael Sahines
  • Patent number: 11013446
    Abstract: A system for secure physiological data acquisition and delivery is provided. The system includes a monitoring patch that includes a flexible backing; a pair of electrocardiographic electrodes included on a contact surface of each end of the flexible backing; a receptacle affixed to a non-contacting surface of the flexible backing and including an electro-mechanical docking interface for interfacing with a monitor recorder; a pair of flexible circuit traces affixed at each end of the flexible backing with each circuit trace connecting one of the electrocardiographic electrodes to the electro-mechanical docking interface; and a circuit operable to store an identifier associated with the patch and an encrypted password necessary to access physiological monitoring data obtained using the patch identified by that identifier, the circuit configured to provide via the electro-mechanical docking interface the password and the identifier to the monitor recorder.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: May 25, 2021
    Assignee: BARDY DIAGNOSTICS, INC.
    Inventors: Jason Felix, Ezra M. Dreisbach, Jon Mikalson Bishay, Corey Bailey Williamson, Gust H. Bardy
  • Patent number: 11013922
    Abstract: A system for delivering electrical pulse stimulation to a subject includes a remote control device configured to at least intermittently transmit temporal pulse pattern programming and a stimulation device comprising a control interface, at least one electrode in electrical communication with the control interface, and an input device in at least intermittent communication with the remote control device to receive the temporal pulse pattern programming. The stimulation device is configured to deliver electrical pulse stimulation to a subject via the at least one electrode according to the temporal pulse pattern programming.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: May 25, 2021
    Assignee: Duke University
    Inventors: Warren M. Grill, Tianhe Zhang
  • Patent number: 11013419
    Abstract: A wearable defibrillator includes garment configured to be worn by a patient, treatment electrodes configured to apply electric current to the patient, and an alarm module configured to provide audio, visual, and haptic notifications. The notifications are configured to indicate that an electric current will be administered imminently, and prompt the patient to provide a response input. The wearable defibrillator includes a motion sensor configured to detect motion and a lack of motion of the patient, and a controller in electrical communication with the alarm module and the motion sensor. The controller is configured to monitor for the response input, cause administration of the electric current to be delayed or cancelled if the response input is received and motion of the patient is detected, and cause administration of the electric current to be delivered if no response input from the patient is received and a lack of motion is detected.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: May 25, 2021
    Assignee: ZOLL Medical Corporation
    Inventors: Edward J Donnelly, Thomas E Kaib, Marshal W Linder, Steven J Szymkiewicz, Jason T Whiting, Shane S Volpe
  • Patent number: 11000686
    Abstract: The present disclosure relates to neuromodulation electrodes, and in particular, to neuromodulation electrodes having a platinum/iridium surface etched with a pattern and methods of laser etching the pattern into the platinum/iridium surface of the neuromodulation electrodes to improve performance of the neuromodulation electrodes. Particularly, aspects are directed to an electrode including a base body having: (i) an interface surface that has an area of less than 50 mm2, and (ii) an alloy including platinum and iridium. The interface surface has a surface topography including: (i) an artificial pattern, and (ii) a surface roughness having an arithmetical mean height (Ra) of greater than 0.8 ?m.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: May 11, 2021
    Assignee: VERILY LIFE SCIENCES LLC
    Inventors: Huanfen Yao, Kathy Jackson
  • Patent number: 11000208
    Abstract: Devices and methods for treating obstructive sleep apnea by first performing an assessment of the patient that involves observing the patient's upper airway during a tongue protrusion maneuver. The assessment may, for example, be done using endoscopy to observe the upper airway while the patient is awake in the supine position. An adequate response of the upper airway during the tongue protrusion maneuver is indicative of likely therapeutic success with hypoglossal nerve stimulation, and may be used for making clinical decisions. The principles of the present invention may be applied to other therapeutic interventions for OSA involving the upper airway.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: May 11, 2021
    Assignee: LivaNova USA, Inc.
    Inventors: Wondimeneh Tesfayesus, Stephen L. Bolea, Peter R. Eastwood, David R. Hillman
  • Patent number: 10994143
    Abstract: Waveforms for a stimulator device, and methods and circuitry for generating them, are disclosed having high- and low-frequency aspects. The waveforms comprise a sequence of pulses issued at a low frequency which each pulse comprising first and second charge-balanced phases. One or both of the phases comprises a plurality a monophasic sub-phase pulses issued at a high frequency in which the sub-phase pulses are separated by gaps. The current during the gaps in a phase can be zero, or can comprise a non-zero current of the same polarity as the sub-phase pulses issued during that phase. The disclosed waveforms provide benefits of high frequency stimulation such as the promotion of paresthesia free, sub-threshold stimulation, but without drawbacks inherent in using high-frequency biphasic pulses.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: May 4, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Goran N. Marnfeldt, Kiran K. Gururaj, Rafael Carbunaru
  • Patent number: 10994142
    Abstract: A system is disclosed in one example which allows for modelling the wellness of a given Implantable Pulse Generator (IPG) patient. The modelling, embodied in an algorithm, uses one or more qualitative measurements and one or more quantitative measurements taken from the patient. The algorithm correlates the qualitative measurements to the various quantitative measurements to eventually, over time, learn which quantitative measurements best correlate to the qualitative measurements provided by the patient. The algorithm can then using current quantitative measurements predict a wellness factor or score for the patient, which is preferably weighted to favor the quantitative measurements that best correlate to that patient's qualitative assessment of therapy effectiveness. Additionally, the wellness factor may be used to adjust the stimulation program that the IPG device provides to the patient.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: May 4, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Michael A. Moffitt
  • Patent number: 10994132
    Abstract: The present invention relates to a system and methods for noninvasively providing therapy for movement disorder symptoms. The present invention provides such a therapy system which provides trans-cranial direct current stimulation (tDCS) in order to treat those symptoms and the disorders. The present invention further provides such tDCS therapy while the subject sleeps in order to minimize the time required and impact of the therapy on the subject's waking life. The system, methods, and devices of the present invention are intended to provide a low-dose electrical current, trans-cranially, to a specific area of the subject's brain while he or she sleeps in order to decrease the occurrence, severity, and duration of the symptoms of movement disorders. The present invention aims to reduce the amount of medication necessary, counteract the effects of medication wearing off during sleep, and to overall improve the quality of life of subjects suffering from movement disorders.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: May 4, 2021
    Assignee: Great Lakes NeuroTechnologies Inc.
    Inventors: Dustin A Heldman, Joseph P Giuffrida
  • Patent number: 10980602
    Abstract: A system and method for obtaining an OIS coordinate frame comprising an electronic control unit configured to determine a local 3D electric field loop, create a zero mean version of E(t) over a depolarization interval, compute an ? value at each of a plurality of time intervals, compute an initial estimate of ? from a cross product of E and the ? value for each of the plurality of time intervals, average the initial estimate of ? from each of the plurality of time for a best estimate of ?, determine a plurality of â(?) values and using the corresponding {circumflex over (n)}(?) values, compute a composite match score, and choose at least one best value for â and a best value for {circumflex over (n)}.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: April 20, 2021
    Assignee: St. Jude Medical, Cardiology Division, Inc.
    Inventors: D. Curtis Deno, Ram K. Balachandran, Stéphane Massé
  • Patent number: 10966659
    Abstract: A system, apparatus, and method using multiple complementary sensors for the monitoring and wireless communication of several respiration characteristics—that is badge-size, wearable on the outside of clothing, and non-invasive.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: April 6, 2021
    Assignee: Xtrava, Inc.
    Inventor: Sameh Sarhan
  • Patent number: 10967172
    Abstract: An apparatus for implanting electrodes in neural tissue to connect a neural modulator to the tissue to send and receive signals from the neural tissue and a method for implanting the electrodes.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: April 6, 2021
    Assignee: Bionic Eye Technologies, Inc.
    Inventors: Douglas B Shire, Lauren N Ayton, Patricia I Wong, Marcus D Gingerich
  • Patent number: 10966742
    Abstract: A medical device can include a working end comprising a jaw mechanism configured to perform a clamping function and a translating cutting mechanism configured to perform a cutting function in response to translating movement of the translating cutting mechanism. The medical device can further include at least two user-actuated input mechanisms, and a computer processor operably coupled to the working end and to the at least two user-actuated control input mechanisms.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: April 6, 2021
    Assignee: INTUITIVE SURGICAL OPERATIONS, INC.
    Inventors: David J. Rosa, Salvatore J. Brogna
  • Patent number: 10964431
    Abstract: An external control device for use with a neurostimulator coupled to a plurality of electrodes capable of conveying electrical stimulation energy into tissue in which the electrodes are implanted. The external control device comprises a user interface including at least one control element, a processor configured for independently assigning stimulation amplitude values to a first set of the electrodes, for linking the first set of electrodes together in response to the actuation of the at least one control element, and for preventing the stimulation amplitude values of the first linked set of electrodes from being varied relative to each other, and output circuitry configured for transmitting the stimulation amplitude values to the neurostimulator.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: March 30, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Prakash Rao, Sridhar Kothandaraman, Christopher Britton Gould
  • Patent number: 10959680
    Abstract: Systems are provided for generating data representing electromagnetic states of a heart for medical, scientific, research, and/or engineering purposes. The systems generate the data based on source configurations such as dimensions of, and scar or fibrosis or pro-arrhythmic substrate location within, a heart and a computational model of the electromagnetic output of the heart. The systems may dynamically generate the source configurations to provide representative source configurations that may be found in a population. For each source configuration of the electromagnetic source, the systems run a simulation of the functioning of the heart to generate modeled electromagnetic output (e.g., an electromagnetic mesh for each simulation step with a voltage at each point of the electromagnetic mesh) for that source configuration.
    Type: Grant
    Filed: October 27, 2020
    Date of Patent: March 30, 2021
    Assignee: Vektor Medical, Inc.
    Inventor: Christopher Villongco
  • Patent number: 10960209
    Abstract: Modulation of neural signaling of a branch of the GSN supplying the adrenal gland can regulate the secretion of signaling molecules from the adrenal medulla. In particular, epinephrine, norepinephrine and enkephalin release can be independently regulated.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: March 30, 2021
    Assignees: Galvani Bioelectronics Limited, Case Western Reserve University
    Inventors: Arun Sridhar, Corey Smith, Kyle Wolf, Georgy Zarkua, Shyue-An Chan
  • Patent number: 10952775
    Abstract: An orientation sensor that includes a user input device that is configured to set a heading of the orientation sensor based on an orientation of the orientation sensor. The orientation sensor may include a memory that is configured to store the heading. The orientation sensor may include a display that is configured to display the at least one orientation value. The orientation sensor may include a processor that is configured to generate orientation information based on the heading. The user input device may include a button, and in response to pressing the button the heading may be set based on the current orientation of the orientation sensor. For example, the at least one orientation value may be associated with orientation data detected by an orientation sensing component, and the at least one orientation value may be displayed based on the heading.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: March 23, 2021
    Assignee: Prichard Medical, LLC
    Inventor: Joseph Prichard Drain
  • Patent number: 10953145
    Abstract: A connector assembly for connecting external power sources to an implanted medical device enables continual supply of electrical power to the implanted medical device during replacement of an external power source. A connector assembly includes a distal driveline contact assembly, a first driveline contact assembly, and a second driveline contact assembly. The second driveline contact assembly is connectable to the distal driveline contact assembly prior to disconnection of the first driveline contact assembly from the distal driveline contact assembly.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: March 23, 2021
    Assignee: TCI LLC
    Inventor: Ethan Petersen
  • Patent number: 10946199
    Abstract: A neurostimulation system (NS) includes an array of electrodes positioned within a patient with an active cathode electrode located proximate to target neural tissue. A control circuit is controls delivery of therapy during a therapy delivery interval, with the therapy being delivered between an anode electrode and the active electrode. A current regulator circuit (CRC) is connected to the cathode electrode and controls current flow through the cathode electrodes. The control circuit manages the CRC to control a discharge current flow over the discharge operation to discharge developed residual voltage between the anode electrode and the active electrode in a manner that follows an actively emulated passive discharge (AEPD) profile. During the discharge operation, the CRC is connected to the inactive electrode, and receives, as a first input, an EMI feedback signal.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: March 16, 2021
    Assignee: ADVANCED NEUROMODULATION SYSTEMS, INC.
    Inventors: Steven Boor, Daran DeShazo
  • Patent number: 10946188
    Abstract: A method and apparatus for the concurrent treatment of multiple oral diseases and defects while promoting general oral hygiene utilizing direct current electricity and methods for manufacturing the same. Electrodes are used to deliver a direct current to the gingival tissues of a mouth in order to achieve a number of therapeutic, prophylactic, and regenerative benefits. These benefits include killing oral microbes, increasing oral vasodilation, reducing oral biofilm, improving oral blood circulation, reversing oral bone resorption, promoting oral osteogenesis, treating gum recession, and fostering gingival regeneration. Other benefits include the treatment of gingivitis, periodontitis, and oral malodor, and other systemic diseases correlated with oral pathogens.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: March 16, 2021
    Assignee: Biolectrics LLC
    Inventors: Issam Nemeh, William J. Leimkuehler, Jr., James G. Azlein, David Mandel, Leon Marucchi, Michael Keller, David Pierson